Long-duration therapy with low molecular weight heparin in patients with antiphospholipid antibody syndrome resistant to warfarin therapy.
Dentali
F
F
Manfredi
E
E
Crowther
M
M
Ageno
W
W
D016736:Antiphospholipid Syndrome / Q000188:drug therapy*; D004351:Drug Resistance; D005260:Female; D006495:Heparin, Low-Molecular-Weight / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D016879:Salvage Therapy; D014859:Warfarin / Q000627:therapeutic use
D006495:Heparin, Low-Molecular-Weight; D014859:Warfarin